8 years ago

Cardian Raises £1.5 Million Seed Funding for Implantable Cardiac Device

  • Cardian, a UK-based startup developing an implantable device for continuous blood pressure monitoring in cardiac failure patients, has secured £1.5 million in seed funding from Touchstone Innovations

  • The company's device is fully implantable and wireless, allowing for real-time monitoring of pulmonary arterial pressure during daily activity

  • Cardian was spun out of Imperial College London and is led by CEO Sandeep Yadav, who previously held the position of COO at Cardiomems, a company acquired by St Jude Medical for $450 million in 2014.

      • ProblemHealthcare

      "Current methods of monitoring heart failure patients are cumbersome and limited, requiring patients to be hospitalized for accurate readings. This leads to inefficient care and can worsen the patient's condition."

      Solution

      "Cardian's implantable device allows continuous, wireless monitoring of blood pressure in the pulmonary artery, providing real-time data on the patient's condition without the need for hospitalization. This enables more effective and timely treatment for heart failure patients."

      Covered on